腺病毒携带骨形态发生蛋白14基因转染脂肪干细胞修复损伤关节软骨

背景：关节软骨损伤后自我修复能力较弱,主要是由于其缺乏滋养血管并且细胞代谢缓慢等组织特性,目前的治疗方法都不能恢复软骨组织的原有功能,近年来软骨组织工程已引起了越来越多的关注。 目的：观察Ⅰ型胶原海绵支架搭载骨形态发生蛋白14基因转染脂肪干细胞修复兔膝关节软骨损伤的效果。 方法：取兔皮下脂肪组织分离培养脂肪干细胞,用腺病毒真核表达载体Ad-CMV-BMP-14-IRES-hrGFP-1转染脂肪干细胞。Ⅰ型胶原海绵支架搭载转染后的脂肪干细胞,待细胞吸附后对兔膝关节全层软骨缺损进行修复。术后12周取手术关节,从大体方面、组织学方面综合评估缺损修复状况。 结果与结论：骨形态发生蛋白14转染后的脂肪干细胞骨形态发生蛋白14和Ⅱ型胶原蛋白表达及Sox-9基因表达明显高于普通脂肪干细胞。术后12周,支架搭载经骨形态发生蛋白14转染的脂肪干细胞组软骨组织修复良好,平整光滑,光洁度、质地及颜色良好,交界区整合良好。支架搭载脂肪干细胞组软骨组织部分修复,有正常软骨光泽,质地与颜色接近正常,修复组织与正常软骨组织界限明显。单纯支架组几乎崩解塌陷,未见透明样软骨结构形成。结果可见腺病毒携带骨形态发生蛋白14基因转染后脂肪干细胞修复软骨缺损的能力有大幅提升。中国组织工程研究杂志出版内容重点：干细胞;骨髓干细胞;造血干细胞;脂肪干细胞;肿瘤干细胞;胚胎干细胞;脐带脐血干细胞;干细胞诱导;干细胞分化;组织工程全文链接：     

Transplantation of allogeneic chondrocytes cultured in fibroin sponge and stirring chamber to promote cartilage regeneration

Cartilage regeneration using a fibroin sponge and a stirring chamber was investigated to improve the potential of articular cartilage tissue engineering. Chondrocytes seeded on the fibroin-sponge scaffolds were cultured in the stirring chamber (a bioreactor facilitating mechanical stimulation) for up to 3 weeks. Changes in DNA content, glycosaminoglycan (GAG) amount, integrin subunits alpha5 and beta1 fluorescence intensity, and morphologic appearance, were studied to evaluate tissue maturity. Seeded scaffolds subjected to the stirring chamber demonstrated significant increases in both DNA content (38.9%) and GAG content (54.3%) at day 21 compared to the control group. In addition, the stirring chamber system facilitated a maturation of cartilage tissue showed by histologic examination, after a staining of proteoglycan and type II collagen. Clinical feasibility of the fibroin and stirring chamber system was evaluated using rabbit models with cartilage defect. Large defects on rabbit knee joints were repaired with regenerated cartilage, which resembles hyaline cartilage at 12 weeks after operation. These studies demonstrated the potential of such mechanically stimulated scaffold/cell constructs to support chondrogenesis in vivo.     

Ⅱ型胶原水凝胶-细胞复合物在软骨损伤中的应用

BACKGROUND: As the main component of articular cartilage, type II collagen can induce bone marrow mesenchymal stem cells to differentiate into the cartilage. However, there is no uniform standard for the preparation of type II collagen hydrogel and its usage in the repair of sports-induced cartilage injury. OBJECTIVE:To investigate the effect of type II collagen hydrogel-cell complexes in the repair of cartilage injury. METHODS: After modeling, 30 New Zealand rabbits with cartilage injury were randomized into two groups (n=15 per group): type II collagen hydrogel-bone marrow mesenchymal stem cell complexes were implanted into the injured site of rabbits in experimental group, while only type II collagen hydrogel implanted in control group. Histomorphology observation was performed by hematoxylin-eosin and toluidine blue staining after 4 and 8 weeks after implantation. RESULTS AND CONCLUSION: In the experimental group, there were inflammatory cells infiltrated at the injured site, most of which were macrophages and only a small amount of which were neutrophils under hematoxylin-eosin staining, at 4 weeks after implantation, while toluidine blue staining showed no positive. At 8 weeks after implantation, a large amount of chondrocytes proliferated at the injured site that was repaired by chondroblasts and myotubes as well as new vessels under hematoxylin-eosin staining, and toluidine blue staining showed the injured tissues were similar to normal tissues. In the control group, at 4 weeks after implantation, obvious interstitial edema existed, whereas skeletal muscle cells disappeared around the injured site, and a lot of inflammatory cells infiltrated. Several chondroblasts formed at 8 weeks, accompanied by increased fibrous tissues. Moreover, toluidine blue staining always showed no positive in the control group. To conclude, the type II collagen hydrogel-cell complex has better chondrogenic ability that can be used for cartilage repair.     

Long-term effects of knitted silk–collagen sponge scaffold on anterior cruciate ligament reconstruction and osteoarthritis prevention

Anterior cruciate ligament (ACL) is difficult to heal after injury due to the dynamic fluid environment of joint. Previously, we have achieved satisfactory regeneration of subcutaneous tendon/ligament with knitted silk–collagen sponge scaffold due to its specific “internal-space-preservation” property. This study aims to investigate the long-term effects of knitted silk–collagen sponge scaffold on ACL regeneration and osteoarthritis prevention. The knitted silk–collagen sponge scaffold was fabricated and implanted into a rabbit ACL injury model. The knitted silk–collagen sponge scaffold was found to enhance migration and adhesion of spindle-shaped cells into the scaffold at 2 months post-surgery. After 6 months, ACL treated with the knitted silk–collagen sponge scaffold exhibited increased expression of ligament genes and better microstructural morphology. After 18 months, the knitted silk–collagen sponge scaffold-treated group had more mature ligament structure and direct ligament-to-bone healing. Implanted knitted silk–collagen sponge scaffolds degraded much more slowly compared to subcutaneous implantation. Furthermore, the knitted silk–collagen sponge scaffold effectively protected joint surface cartilage and preserved joint space for up to 18 months post-surgery. These findings thus demonstrated that the knitted silk–collagen sponge scaffold can regenerate functional ACL and prevent osteoarthritis in the long-term, suggesting its clinical use as a functional bioscaffold for ACL reconstruction.     

Regeneration of whole meniscus using meniscal cells and polymer scaffolds in a rabbit total meniscectomy model

The current treatments of meniscal lesion in knee joint are not perfect to prevent adverse effects of meniscus injury. Tissue engineering of meniscus using meniscal cells and polymer scaffolds could be an alternative option to treat meniscus injury. This study reports on the regeneration of whole medial meniscus in a rabbit total meniscectomy model using the tissue engineering technique. Biodegradable scaffolds in a meniscal shape were fabricated from polyglycolic acid (PGA) fiber meshes that were mechanically reinforced by bonding PGA fibers at cross points with 75:25 poly(lactic-co-glycolic acid). The compressive modulus of the bonded PGA scaffold was 28-fold higher than that of nonbonded scaffold. Allogeneic meniscal cells were isolated from rabbit meniscus biopsy and cultured in vitro. The expanded meniscal cells were seeded onto the polymer scaffolds, cultured in vitro for 1 week, and transplanted to rabbit knee joints from which medial menisci were removed. Ten or 36 weeks after transplantation, the implants formed neomenisci with the original scaffold shape maintained approximately. Hematoxylin and eosin staining of the sections of the neomenisci at 6 and 10 weeks revealed the regeneration of fibrocartilage. Safranin-O staining showed that abundant proteoglycan was present in the neomenisci at 10 weeks. Masson's trichrome staining indicated the presence of collagen. Immunohistochemical analysis showed that the presence of type I and II collagen in neomenisci at 10 weeks was similar to that of normal meniscal tissue. Biochemical and biomechanical analyses of the tissue-engineered menisci at 36 weeks were performed to determine the quality of the tissue-engineered menisci. Tissue-engineered meniscus showed differences in collagen content and aggregate modulus in comparison with native meniscus. This study demonstrates, for the first time, the feasibility of regenerating whole meniscal cartilage in a rabbit total meniscectomy model using the tissue engineering method.     

Regeneration of whole meniscus using meniscal cells and polymer scaffolds in a rabbit total meniscectomy model

The current treatments of meniscal lesion in knee joint are not perfect to prevent adverse effects of meniscus injury. Tissue engineering of meniscus using meniscal cells and polymer scaffolds could be an alternative option to treat meniscus injury. This study reports on the regeneration of whole medial meniscus in a rabbit total meniscectomy model using the tissue engineering technique. Biodegradable scaffolds in a meniscal shape were fabricated from polyglycolic acid (PGA) fiber meshes that were mechanically reinforced by bonding PGA fibers at cross points with 75:25 poly(lactic-co-glycolic acid). The compressive modulus of the bonded PGA scaffold was 28-fold higher than that of nonbonded scaffold. Allogeneic meniscal cells were isolated from rabbit meniscus biopsy and cultured in vitro. The expanded meniscal cells were seeded onto the polymer scaffolds, cultured in vitro for 1 week, and transplanted to rabbit knee joints from which medial menisci were removed. Ten or 36 weeks after transplantation, the implants formed neomenisci with the original scaffold shape maintained approximately. Hematoxylin and eosin staining of the sections of the neomenisci at 6 and 10 weeks revealed the regeneration of fibrocartilage. Safranin-O staining showed that abundant proteoglycan was present in the neomenisci at 10 weeks. Masson's trichrome staining indicated the presence of collagen. Immunohistochemical analysis showed that the presence of type I and II collagen in neomenisci at 10 weeks was similar to that of normal meniscal tissue. Biochemical and biomechanical analyses of the tissue-engineered menisci at 36 weeks were performed to determine the quality of the tissue-engineered menisci. Tissue-engineered meniscus showed differences in collagen content and aggregate modulus in comparison with native meniscus. This study demonstrates, for the first time, the feasibility of regenerating whole meniscal cartilage in a rabbit total meniscectomy model using the tissue engineering method.     

骨质疏松大鼠膝关节组织总胶原、Ⅰ型及Ⅱ型胶原蛋白的含量变化

背景：目前研究认为胶原蛋白在骨细胞的增殖与分化、骨质的形成和吸收、骨基质矿化等过程中起着非常重要的作用。 目的：观察骨质疏松模型大鼠膝关节组织总胶原、Ⅰ型及Ⅱ型胶原蛋白含量变化。 方法：SD雌性大鼠40只随机分为实验组和对照组,实验组大鼠行双侧卵巢切除16周后,取膝关节软骨和交叉韧带,采用微量羟脯氨酸测定法及酶联免疫吸附法测定大鼠膝关节软骨及前交叉韧带组织总胶原、Ⅰ型及Ⅱ型胶原蛋白含量。 结果与结论：骨质疏松膝关节模型大鼠膝关节软骨、前交叉韧带总胶原、Ⅰ型及Ⅱ型胶原蛋白含量明显下降(P < 0.05),Ⅰ型/Ⅱ型胶原比值也显著降低(P < 0.05),提示骨质疏松可引起膝关节内组织总胶原、Ⅰ型及Ⅱ型胶原含量及其比值改变,与膝关节骨性关节炎的发生密切相关。     

Stem cell-coated titanium implants for the partial joint resurfacing of the knee

The goal of the present study was to evaluate the partial surface replacement of the knee with stem cell-coated titanium implants and to provide a basis for a successful treatment of large osteochondral defects. Mesenchymal stem cells (MSCs) were isolated from bone marrow aspirates of adult sheep. Round titanium implants with a diameter of 2 x 7.3 mm were seeded with autologous MSC and inserted into an osteochondral defect in the medial femoral condyle. As controls, defects received either an uncoated implant or were left untreated. Nine animals with 18 defects were sacrificed after 6 months. Histological evaluation was performed by intravital polychrome fluorescent labelling, intravital perfusion with Indian ink, microradiographs and differential staining with toluidine blue. The quality of regenerated cartilage was assessed by in situ hybridization of collagen type II and immunohistochemistry of collagen types I and II. In 50% of the cases, defects treated with MSC-coated implants showed a complete regeneration of the subchondral bone layer. In these cases collagen type II and only traces of collagen type I were detected. A high level of collagen type II mRNA expression compared to articular cartilage indicates regenerating hyaline-like cartilage. A total of 50% of MSC-coated and uncoated implants failed to osseointegrate and formation of fibrocartilage was observed. Untreated defects as well as defects treated with uncoated implants demonstrated incomplete healing of subchondral bone and formation of fibrous cartilage. A modified histological score according to Wakitani significantly demonstrated better results for cell-coated implants (8.8+/-6.4) than for uncoated implants (5.5+/-3.9) and for untreated defects (2.8+/-2.5). Our results demonstrate that, in a significant number of cases, a partial joint resurfacing of the knee with stem cell-coated titanium implants occur. A slow bone and cartilage regeneration and an incomplete healing in half of the MSC-coated implants are limitations of the presented method. To improve our approach and optimize the experimental parameters, further investigations are needed prior to clinical application.     

转化生长因子-β及胰岛素样生长因子-Ⅰ修复关节软骨缺损的实验观察

目的观察转化生长因子-β（transforming growth factor-β,TGF-β）、胰岛素样生长因子-Ⅰ（insulin—like growth factor-Ⅰ,IGF-Ⅰ）对关节软骨缺损修复的作用。方法采用组织工程方法制备骨基质明胶（BMG）软骨细胞移植物。将40只4月龄的新西兰兔随机分为TGF-β组、IGF-Ⅰ组、TGF-β联合IGF-Ⅰ组、空白对照组（前三组为实验组）。各组制备关节软骨缺损模型,实验组兔膝关节腔注射对应等量人重组蛋白,对照组注射等量盐水。术后行组织学观察及免疫组化检测。结果TGF-β联合IGF-Ⅰ组软骨细胞生长较快,术后24周修复的软骨组织HE染色与正常关节软骨一致,软骨细胞呈柱状排列,免疫组化见Ⅱ型胶原染色较深;TGF-β组、IGF-Ⅰ组术后24周部分软骨细胞呈柱状排列,免疫组化见Ⅱ型胶原染色较浅;空白对照组未修复。结论联合应用TGF-β及IGF-Ⅰ可较好促进关节软骨缺损修复,其作用优于两者单独应用。     

组织工程软骨与柚皮苷联合修复兔膝关节软骨缺损的组织学证实

背景：目前临床上虽有多种方法用于治疗软骨缺损,但没有从根本上解决关节软骨缺损修复问题。 目的：通过组织学研究进一步评价柚皮苷结合组织工程软骨修复兔关节软骨缺损的效果。 方法：取兔骨髓间充质干细胞体外增殖后,复合于改建后的脱细胞真皮基质载体上,制成组织工程软骨,植入到兔膝关节软骨缺损,并以柚皮苷汤灌胃,于 4,8周后分别对修复组织进行苏木精-伊红、Masson三色染色、甲苯胺蓝染色、Ⅱ型胶原染色、Ⅹ型胶原染色等组织学检查。 结果与结论：术后8周, 柚皮苷结合干细胞复合体组缺损处修复组织变成乳白色,半透明光滑组织,缺损修复组织与周围正常软骨已基本难区分,表面光滑。组织学检查发现修复缺损处基本为新生软骨填充。结果证实,柚皮苷结合组织工程软骨能提高家兔膝关节软骨缺损的修复质量。 中国组织工程研究杂志出版内容重点：组织构建;骨细胞;软骨细胞;细胞培养;成纤维细胞;血管内皮细胞;骨质疏松;组织工程全文链接：     

Development and ageing of the articular cartilage of the rabbit knee joint: distribution of the fibrillar collagens

The development of the articular cartilage of the rabbit knee joint from the 17-day fetus to the 2-year adult rabbit has been examined. At 17 days, the developing femur and tibia are separated by the interzone. Cavitation occurs around 25 days; the cells of the intermediate layer flatten and move onto those of the chondogenous layers to create the articular surfaces. After birth, growth of the cartilage is mainly the result of matrix production. Ossification of the epiphyses is complete by 6 weeks postpartum. Horizontal zones can be distinguished in the articular cartilage; the superficial cells are aligned parallel to the surface, but in the deep layers the cells are in columns. The tidemark is first seen at 12–14 weeks. The matrix of the interzone in the 17-day fetus contains types I, III and V collagens, but no type II. After cavitation at 25 days, the surface layer of the articular cartilage still contains type I, but no type II collagen. From 6 weeks postnatal onwards, type II collagen is present throughout the cartilage and type I disappears. Type III collagen is initially in the interterritorial matrix, but later it is mainly pericellular. Type V collagen is pericellular both in the chondrogenous layers and later in the articular cartilage, but is not present in the epiphyseal cartilage below. From 6 weeks onwards, types III and V collagens create a capsule around all the chondrocytes above the tidemark. The relationship of types V and XI collagens is discussed. It is concluded that the articular chondrocytes form a unique subset of cells from the earliest stages of joint formation in the fetal rabbit.     

The hip joint: the fibrillar collagens associated with development and ageing in the rabbit

The fibrillar collagens associated with the articular cartilages, joint capsule and ligamentum teres of the rabbit hip joint were characterised from the 17 d fetus to the 2-y-old adult by immunohistochemical methods. Initially the putative articular cartilage contains types I, III and V collagens, but when cavitation is complete in the 25 d fetus, type II collagen appears. In the 17 d fetus, the cells of the chondrogenous layers express type I collagen mRNA, but not that of type II collagen. Types III and V collagens are present throughout life, particularly pericellularly. Type I collagen is lost. In all respects, the articular cartilage of the hip joint is similar to that of the knee. The joint capsule contains types I, III and V collagens. In the fetus the ligamentum teres contains types I and V collagens and the cells express type I collagen mRNA; type III collagen is confined mainly to its surface and insertions. After birth, the same distribution remains, but there is more type III collagen in the ligament, proper. The attachment to the cartilage of the head of the femur is marked only by fibres of type I collagen traversing the cartilage; the attachment cannot be distinguished in preparations localising types III and V collagens. The attachment to the bone at the lip of the acetabulum is via fibres of types I and V collagens and little type III is present. The ligament is covered by a sheath of types III and V collagens. Type II collagen was not located in any part of the ligamentum teres. The distribution of collagens in the ligamentum teres is similar to that in the collateral ligaments of the knee. Its insertions are unusual because no fibrocartilage was detected.     

Role of insulin like growth factor-I in repair response in immature cartilage

OBJECTIVE: The purpose of this study was to investigate the effects of exogenous local Insulin like growth factor-I (IGF-I) on the repair of full-thickness articular cartilage defects in immature rabbits. DESIGN: Thirty-six skeletally immature New Zealand rabbits between 6 and 8 weeks old were used. A single defect, 3.5-mm-wide by 4-mm-deep full-thickness articular cartilage defect in the medial femoral condyle, was created. The defect was either filled with a collagen sponge or with a collagen sponge impregnated with 5 mug of recombinant IGF-I. The animals were sacrificed at 4, 8 or 12 weeks, and the repair tissue was examined macroscopically and histologically. Repair tissue was also examined immunohistochemically for the presence of type-I collagen, type-II collagen and PCNA at all weeks. RESULTS: Newly formed tissue in all of the defects in the IGF-I group had the gross, histological and histochemical appearance of a smooth, intact hyaline articular cartilage. The average total scores on the histological grading scale were significantly better (p<0.05) for the defects treated with recombinant IGF-I at all time points. Immunostaining with an antibody against type-II collagen showed the diffuse presence of the repair cartilage in the IGF-I treated defects. The control groups demonstrated minimum staining with type-II collagen antibody. CONCLUSIONS: These findings suggest that repair of full-thickness immature cartilage defects can be enhanced by recombinant IGF-I.     

兔膝关节神经支选择性切断后对关节软骨的影响

目的观察兔膝关节神经支选择性切断后关节软骨形态学变化。方法在外科显微镜下选择性切断兔膝关节神经支,术后4、8、16周取材,肉眼观察兔膝关节大体结构,组织切片HE染色,光镜下观察关节软骨组织结构,应用显微电脑测量软件测量关节软骨厚度。结果对照组兔膝关节软骨表面光滑,软骨细胞呈四层结构排列,软骨细胞为圆形或椭圆形,表层呈梭形。实验组兔膝关节软骨组织结构未见明显改变,软骨厚度与对照组比较差异无统计学意义(P0.05)。结论选择性切断兔膝关节神经支对关节软骨组织结构无明显影响,膝关节局部去神经化术治疗具有可行性。     

The use of poly(lactic-co-glycolic acid) microspheres as injectable cell carriers for cartilage regeneration in rabbit knees

The use of injectable scaffolding materials for in vivo tissue regeneration has raised great interest because it allows cell implantation through minimally invasive surgical procedures. Previously, we showed that poly(lactic-co-glycolic acid) (PLGA) microspheres can be used as an injectable scaffold to engineer cartilage in the subcutaneous space of athymic mice. The purpose of this study was to determine whether PLGA microspheres can be used as an injectable scaffold to regenerate hyaline cartilage in the osteochondral defects of rabbit knees. A full-thickness wound to the patellar groove of the articular cartilage was made in the knees of rabbits. Rabbit chondrocytes were mixed with PLGA microspheres and injected immediately into these osteochondral wounds. Both chondrocyte transplantations without PLGA microspheres and culture medium injections without chondrocytes served as controls. Sixteen weeks after implantation, chondrocytes implanted using the PLGA microspheres formed white cartilaginous tissues. Histological scores indicating the extent of the cartilaginous tissue repair and the absence of degenerative changes were significantly higher in the experimental group than in the control groups (P < 0.05). Histological analysis by a hematoxylin and eosin stain of the group transplanted with microspheres showed thicker and better-formed cartilage compared to the control groups. Alcian blue staining and Masson's trichrome staining indicated a higher content of the major extracellular matrices of cartilage, sulfated glycosaminoglycans and collagen in the group transplanted with microspheres than in the control groups. In addition, immunohistochemical analysis showed a higher content of collagen type II, the major collagen type in cartilage, in the microsphere transplanted group compared to the control groups. In the group transplanted without microspheres, the wounds were repaired with fibro-cartilaginous tissues. This study demonstrates the feasibility of using PLGA microspheres as an injectable scaffold for cartilage regeneration in a rabbit model of osteochondral wound repair.     

The use of poly(lactic-co-glycolic acid) microspheres as injectable cell carriers for cartilage regeneration in rabbit knees

The use of injectable scaffolding materials for in vivo tissue regeneration has raised great interest because it allows cell implantation through minimally invasive surgical procedures. Previously, we showed that poly(lactic-co-glycolic acid) (PLGA) microspheres can be used as an injectable scaffold to engineer cartilage in the subcutaneous space of athymic mice. The purpose of this study was to determine whether PLGA microspheres can be used as an injectable scaffold to regenerate hyaline cartilage in the osteochondral defects of rabbit knees. A full-thickness wound to the patellar groove of the articular cartilage was made in the knees of rabbits. Rabbit chondrocytes were mixed with PLGA microspheres and injected immediately into these osteochondral wounds. Both chondrocyte transplantations without PLGA microspheres and culture medium injections without chondrocytes served as controls. Sixteen weeks after implantation, chondrocytes implanted using the PLGA microspheres formed white cartilaginous tissues. Histological scores indicating the extent of the cartilaginous tissue repair and the absence of degenerative changes were significantly higher in the experimental group than in the control groups (P < 0.05). Histological analysis by a hematoxylin and eosin stain of the group transplanted with microspheres showed thicker and better-formed cartilage compared to the control groups. Alcian blue staining and Masson's trichrome staining indicated a higher content of the major extracellular matrices of cartilage, sulfated glycosaminoglycans and collagen in the group transplanted with microspheres than in the control groups. In addition, immunohistochemical analysis showed a higher content of collagen type II, the major collagen type in cartilage, in the microsphere transplanted group compared to the control groups. In the group transplanted without microspheres, the wounds were repaired with fibro-cartilaginous tissues. This study demonstrates the feasibility of using PLGA microspheres as an injectable scaffold for cartilage regeneration in a rabbit model of osteochondral wound repair.     

骨髓间充质干细胞移植治疗颞下颌关节骨关节病

背景：随着干细胞技术的发展,利用组织工程技术修复软骨损伤成为一种可能,而骨髓间充质干细胞由于其优良的特性成为研究重点。 目的：通过体外培养骨髓间充质干细胞,注入兔颞下颌关节紊乱病动物模型,观察干细胞对兔颞下颌关节紊乱病的治疗效果。 方法：通过体外全血贴壁法培养骨髓间充质干细胞并进行鉴定;细胞在体外扩增,诱导成软骨细胞后待用。以Ⅱ型胶原酶进行颞下颌关节腔内注射,建立颞下颌关节紊乱病动物模型,关节腔内注射诱导后成软骨细胞设为实验组,对照组注射未进行诱导的细胞进行比较,通过观察动物咀嚼和组织切片观察治疗效果。 结果与结论：实验分离的细胞7-14 d可见少量集落形成,20 d时观察见细胞基本铺满瓶底。经stro-1⁺、CD44⁺流式细胞及免疫组化测定细胞表达间充质干细胞特性;细胞在诱导成软骨细胞后Ⅱ型胶原免疫组化染色强阳性。兔颞下颌关节注射胶原酶可在2周时出现偏侧咀嚼症状,骨髓间充质干细胞诱导的成软骨细胞关节腔注入动物模型后,实验组明显弱于对照组。组织切片显示诱导的成软骨细胞可促进关节损伤的修复,软骨及胶原生成多于对照组。说明骨髓间充质诱导的成软骨细胞关节腔注入后可促进兔颞下颌关节骨关节病愈合。     

A Collagen–Poly(Vinyl Alcohol) Nanofiber Scaffold for Cartilage Repair

Articular cartilage has a limited capacity for self-repair. Untreated injuries of cartilage may lead to osteoarthritis. This problem demands new effective methods to reconstruct articular cartilage. Mesenchymal stem cells (MSCs) have the proclivity to differentiate along multiple lineages giving rise to new bone, cartilage, muscle, or fat. This study was an animal model for autologous effects of transplantation of MSCs with a collagen–poly(vinyl alcohol) (PVA) scaffold into full-thickness osteochondral defects of the stifle joint in the rabbit as an animal model. A group of 10 rabbits had a defect created experimentally in the full thickness of articular cartilage penetrated into the subchondral space in the both stifle joints. The defect in the right stifle was filled with MSCs/collagen–PVA scaffold (group I), and in the left stifle, the defect was left without any treatment as the control group (group II). Specimens were harvested at 12 weeks after implantation, examined histologically for morphologic features, and stained immunohistochemically for type-II collagen. Histology observation showed that the MSCs/collagen–PVA repair group had better chondrocyte morphology, continuous subchondral bone, and much thicker newly formed cartilage compared with the control group at 12 weeks post operation. There was a significant difference in histological grading score between these two groups. The present study suggested that the hybrid collagen–PVA scaffold might serve as a new way to keep the differentiation of MSCs for enhancing cartilage repair.     

Increased urinary concentration of collagen type II C-telopeptide fragments in patients with osteoarthritis.

OBJECTIVE: Osteoarthritis (OA) is characterized by a progressive degeneration of articular cartilage and loss of joint function. We hypothesized that degradation of articular cartilage results in increased fragmentation of collagen type II. Thus, the concentrations of degradation products of this major cartilage matrix protein may increase in body fluids of patients with OA. METHODS: Monoclonal antibodies specific for a human collagen type II C-telopeptide (CTx-II) fragment were used in an ELISA for quantification of collagen type II fragments in urine. Clinical assessment of 88 patients with advanced OA of either hip or knee and 48 age-matched controls was performed with the Harris hip score, the Merle d'Aubigné score and a knee score. Joint space narrowing and the Kellgren and Lawrence score were assessed as radiological signs of OA. RESULTS: The concentration of CTx-II was significantly higher in OA patients compared with controls (527 vs. 190 ng/mmol, p < 0.001) whether the patients were diagnosed with hip OA (n = 51) or knee OA (n = 37). Mean CTx-II levels were higher in hip OA than in knee OA and a slight increase in levels with age was observed in the controls, but not in OA subjects. CONCLUSION: Elevation of CTx-II in urine of patients with severe OA compared with a control group suggests that collagen type II derived fragments may serve as markers for OA.     

两种可注射Pluronic F-127水凝胶复合物修复兔软骨缺损的效果差异

文题释义：Pluronic F-127：是一种聚氧化乙烯-聚氧化丙烯-聚氧化乙烯三嵌段共聚物,具有在低温下为液态、常温下为固态的特性,为温固化水凝胶,具有良好的生物相容性与生物可降解性。作为组织工程中的细胞支架,Pluronic F-127已被广泛应用于软骨与皮肤等的构建。 SOX9基因：在性别决定与分化过程中具有重要的作用,在胚胎发育过程中参与骨的形成,同时其也参与神经系统与胰腺的发育及肿瘤的发生。在骨骼形成过程中,SOX9通过与 DNA 特定区域结合促进间充质细胞的聚集：首先是在软骨前体细胞中,随后是在分化中的或成熟的前体细胞中表达,维持软骨细胞增殖,抑制其向肥大软骨细胞分化,因此SOX9在软骨形成过程中起着十分重要的作用。 背景：预实验显示,SOX9基因转染的骨髓间充质干细胞可在Pluronic F-127水凝胶内良好的生长与增殖,促进细胞外基质的分泌,增加软骨基质的表达。 目的：利用慢病毒基因诱导方式将SOX9基因转导至骨髓间充质干细胞中,将其与可注射Pluronic F-127水凝胶复合,观察Pluronic F-127水凝胶复合物修复软骨缺损的效果。 方法：利用慢病毒基因诱导方式将SOX9基因转导至骨髓间充质干细胞中,转染48 h后与Pluronic F-127水凝胶复合。取60只新西兰大白兔(武汉科技大学实验动物中心提供),建立右侧膝关节股骨髁软骨缺损模型,随机分3组处理：模型组缺损部位未植入任何材料,对照组植入未转染的骨髓间充质干细胞与Pluronic F-127水凝胶复合物,实验组植入SOX9基因转染的骨髓间充质干细胞与Pluronic F-127水凝胶复合物。术后4,12周取缺损部位组织,分别进行Micro-CT三维重建、苏木精-伊红染色、番红O染色、Ⅱ型胶原免疫组织化学染色与Wakitani软组织损伤修复组织学评分。实验获得武汉科技大学伦理委员会批准。 结果与结论：①术后12周Micro-CT三维重建显示,模型组缺损区域未见明显的修复,中央仍有较大的凹陷;对照组可见明显的修复,中央凹陷区域明显减小,可见较多的再生骨小梁结构;实验组缺损部位基本完成修复;②术后12周苏木精-伊红染色显示,模型组缺损区仍未见骨小梁结构,细胞分布紊乱,未见软骨陷窝;对照组可见较多的骨组织重建,缺损区域主要由软骨样组织与纤维组织填充;实验组骨组织重建较充分,缺损区域主要由软骨样细胞与软骨样细胞外基质填充,细胞呈柱状排列,与周围软骨相似;③术后12周番红O染色与Ⅱ型胶原免疫组织化学染色显示,模型组可见少量糖胺多糖表达,未见Ⅱ型胶原表达;对照组可见较多的糖胺多糖与Ⅱ型胶原表达,实验组糖胺多糖与Ⅱ型胶原表达最多;④实验组Wakitani软组织损伤修复组织学评分高于对照组与模型组(P < 0.05);⑤结果表明,负载SOX9基因转染骨髓间充质干细胞的Pluronic F-127水凝胶复合物可促进软骨缺损的修复。 ORCID: 0000-0002-9648-5297(樊薰勤) 中国组织工程研究杂志出版内容重点：生物材料;骨生物材料; 口腔生物材料; 纳米材料; 缓释材料; 材料相容性;组织工程